Back to Search
Start Over
Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients
- Source :
- Biology of Blood and Marrow Transplantation. 23:S191-S192
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- Oncology
Transplantation
medicine.medical_specialty
business.industry
030232 urology & nephrology
Phases of clinical research
Hematopoietic stem cell
Maribavir
Valganciclovir
Hematology
Pre emptive treatment
03 medical and health sciences
0302 clinical medicine
medicine.anatomical_structure
030220 oncology & carcinogenesis
Internal medicine
medicine
business
Solid organ transplantation
Cytomegalovirus viremia
medicine.drug
Subjects
Details
- ISSN :
- 10838791
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Biology of Blood and Marrow Transplantation
- Accession number :
- edsair.doi...........f619bf58fe5663ce12389b48c1409ec8